Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Comparative adverse-event reporting patterns of semaglutide and tirzepatide: a disproportionality analysis of FAERS
Endocrine, 2026;91(1)
Dual GIP/GLP-1 receptor agonist versus selective GLP-1 receptor agonist in patients undergoing primary total knee or hip arthroplasty
European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026;36(1)
Semaglutide modulates explore/exploit decision-making in major depressive disorder: A randomized clinical trial
Psychological medicine, 2026;56:e344
Effectiveness of Weekly Semaglutide Treatment (0.5 or 1 mg) in Chilean Patients with Type 2 Diabetes Mellitus
Revista medica de Chile;154(8):1150-1159
Comparative Transcriptomic Profiling of Diabetic Wound Responses to Recombinant Periplaneta americana Thymosin Isoforms in Male ob/ob Mice
Genes, 2026;17(10)
Weight-Loss Outcomes After Sleeve Gastrectomy Versus Tirzepatide in a Minority Cohort With Severe Obesity: Results From a Propensity Score Matched Cohort
Clinical obesity;16(6):e70116
Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease
Medicine;105(41):e51019
Durability of Semaglutide Effects After Treatment Discontinuation in HIV-Associated Lipohypertrophy: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Clinical Trial
Open forum infectious diseases, 2026;13(10):ofag631
Estimating the carbon footprint of oral semaglutide (Rybelsus): a comparative analysis of the medicine carbon footprint model and manufacturer life-cycle assessment in pharmaceutical production
BMJ open, 2026;16(9):e124968
Semaglutide as adjunct treatment for obesity in adolescents receiving antipsychotic medication (the GOAL trial): protocol for a single-arm, open-label feasibility study
BMJ open, 2026;16(9):e123779
Impact of Semaglutide, Liraglutide and Tirzepatide on Cardiometabolic Outcomes: A Comparative Narrative Review
Endocrinology, diabetes & metabolism;9(5):e70338
Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndrome
Frontiers in endocrinology, 2026;17:1881392
Association of tirzepatide with changes in OSA-related measures based on baseline characteristics – post hoc analyses of SURMOUNT-OSA
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2026;22(1)
Digital Engagement and Predictors of Semaglutide Persistence and Weight Loss in Severe Obesity: 48-Week Observational Study
Journal of medical Internet research, 2026;28:e80119
Tirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetes
Nature communications, 2026;17(1)
Sex-based differences in clinical outcomes among patients with obesity and heart failure with preserved ejection fraction treated with tirzepatide
Therapeutic advances in cardiovascular disease, 2026;20:17539447261478928
Achieving the triple endpoint of body weight reduction thresholds, systolic blood pressure reduction ≥5 mmHg and non-HDL cholesterol <130 mg/dL with tirzepatide in people with obesity: A post hoc analysis from the SURMOUNT trials
PloS one, 2026;21(8):e0345032
Liver Fat Changes in Patients With Type 2 Diabetes by Presence of Genetic Hepatic Steatosis: A Post Hoc Analysis of SURPASS-3 MRI
Liver international : official journal of the International Association for the Study of the Liver;46(9):e70837
Obesity management for kidney TRANSPLANTation: protocol for the vanguard phase of an innovative randomised controlled trial, embedded in routine care (OK-TRANSPLANT 2)
BMJ open, 2026;16(8):e120427
Effects of Oral Semaglutide on Dietary Intake and Body Composition in Japanese People With Type 2 Diabetes: A Prospective Observational Study in Clinical Practice
Endocrinology, diabetes & metabolism;9(5):e70295